First
stage of major depressive disorder was diagnosed in 28 year woman. She was
treated with escitalopram up to 10mg/day and her condition improved, with mild
side effects of gastrointestinal discomfort and slight hair fall. After three
months of medication hair fall had become more severe and the patient was
distressed with this condition. Even dermatologist confirmed no other
dermatological reasons for hair fall. The medication was stopped after fourth
months and she could recover hairs quickly.It has been found that Selective
serotonin re-uptake inhibitors (SSRIs) can induce hair loss as a rare and
reversible side effect that may develop in the first few month of treatment and
that is resolved after stopping the taking of the drug.
A number of dermatological side effects of this
type of medication may occur, such as redness or a rash. Also, for hair, the
side effects are not restricted to only hair loss, they can also include
changes to the hair structure and colour.However, hair loss may be limited and
self-restricting, in that sometimes the condition may be general and in other
cases, it can involve the hair over the entire body.Alopecia covers all forms
of hair loss, ranging from simple or partial hair loss to a total loss of body
hair. It is difficult to detect clinically until about 25% or more of the hairis lost.
Therefore, hair loss is usually a subjective complaint by the patient
themself after noticing an increased loss of hair, while physicians often do
not enquire about this side effect and may not recognise it, and even if they
are made aware of it they don’t usually connect it directly with the medication
being taken.Selective serotonin re-uptake inhibitors (SSRIs) are widely used to
treat depressive disorders and a wide range of other disorders, such as eating
disorders, OCD anxiety and borderline personality disorders. Hair loss is a
rare side effect of psychotropic agents.In the literature, valproic acid and
lithium and carbamazepine are among the most commonly prescribed psychotropic
agents. Read more...........

No comments:
Post a Comment